Showing results (71-80 of 315) with videos related to

Sort By:
Pageof 32
European Urology|April 11, 2020
"PSA Surveillance in the Septuagenarian": A Proposed New Terminology for Clinical Follow-up to Assess Risk of Prostate Cancer in Men Aged 70 Years and OlderSigrid V Carlsson, James A Eastham, E David Crawford, et al.
Targeted Oncology|September 20, 2019
Immune Checkpoint Inhibitors as Switch or Continuation Maintenance Therapy in Solid Tumors: Rationale and Current StatePetros Grivas, Bradley J Monk, Daniel Petrylak, et al.
Urology|November 20, 2003
Combination of low-dose flutamide and finasteride for PSA-only recurrent prostate cancer after primary therapyAl Baha Barqawi, Judd W Moul, Ali Ziada, et al.
Urologic Oncology|March 28, 2008
Failure to achieve a complete response to induction BCG therapy is associated with increased risk of disease worsening and death in patients with high risk non-muscle invasive bladder cancerSeth P Lerner, Catherine M Tangen, Heidi Sucharew, et al.
The Journal of Urology|April 18, 2007
Patterns of recurrence and outcomes following induction bacillus Calmette-Guerin for high risk Ta, T1 bladder cancerSeth P Lerner, Catherine M Tangen, Heidi Sucharew, et al.
Urologic Oncology|February 19, 2004
The UroVysion fluorescence in situ hybridization assay is an effective tool for monitoring recurrence of bladder cancerMarileila Varella-Garcia, Bulent Akduman, Patrapim Sunpaweravong, et al.
World Journal of Urology|January 13, 2016
Determining optimal prostate-specific antigen thresholds to identify an increased 4-year risk of prostate cancer development: an analysis within the Veterans Affairs Health Care SystemS Scott Sutton, E David Crawford, Judd W Moul, et al.
The Journal of Urology|July 22, 2015
Treating Patients with Metastatic Castration Resistant Prostate Cancer: A Comprehensive Review of Available TherapiesE David Crawford, Celestia S Higano, Neal D Shore, et al.
The Journal of Urology|January 13, 2006
A 12-month clinical study of LA-2585 (45.0 mg): a new 6-month subcutaneous delivery system for leuprolide acetate for the treatment of prostate cancerE David Crawford, Oliver Sartor, Franklin Chu, et al.
Urology|April 19, 2005
Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening programAl Baha Barqawi, Brian K Golden, Colin O'Donnell, et al.
Pageof 32